Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Iliotibial Band Friction Syndrome Treatment & Management

  • Author: Steven J Karageanes, DO, FAOASM; Chief Editor: Thomas M DeBerardino, MD  more...
 
Updated: Apr 11, 2016
 

Approach Considerations

Failure of conservative therapy for iliotibial band (ITB) friction syndrome (ITBFS) is an indication for surgery. Conservative therapy includes rest, stretching and strengthening exercises, anti-inflammatory medication, other therapy modalities, and biomechanical correction of limb-length discrepancies and pes planus. A minimum trial of 3 months should be given, and all other factors related to ITBFS should be thoroughly addressed before surgery is considered. Even then, surgery is best limited to highly motivated people who want to return to their sport or activity.

Active infection and coagulopathy are contraindications to surgery.

Next

Medical Therapy

The basic principles of treatment include control of inflammation, modification of activity, and correction of underlying problems.[14] An aggressive treatment program is as follows:

Acute phase

Medical therapy consists of nonsteroidal anti-inflammatory drugs (NSAIDs) with adjunctive physical therapy. These drugs reduce the inflammation in the soft tissue. Analgesics, such as acetaminophen or codeine preparations, can be used in persons with functional disability. Injection of corticosteroid can be used when conservative attempts to control inflammation fail or swelling persists for more than 3 days.

Activity modification should be considered. Examine recent changes in training, such as duration and intensity of exercise. Curtail activity to a level at which pain is not generated.

Ice may be applied to the region of inflammation near the lateral femoral condyle, but for no longer than 15 minutes. Ice compresses or cold packs can be used for 20 minutes.

Use hydrocortisone or a similar topical steroid preparation with ultrasound (phonophoresis) or electrical stimulation (iontophoresis) for control of inflammation.

Subacute phase

Begin stretching exercises after inflammation subsides. Restoring proper range of motion in the hip flexors (iliopsoas, quadriceps), hip extensors (gluteus maximus, hamstrings), hip abductors (gluteus medius, tensor fasciae latae), and, most important, the hip adductors is crucial to restoring overall hip function.

Myofascial therapy should focus on treating trigger points and loosening restrictions along the ITB. Target areas include over the lateral femoral condyle and greater trochanter.

Manipulative therapy can be effective in treating areas of restriction and repairing the biomechanical flaws that led to ITBFS. Muscle energy techniques can be safely applied to the tensor fasciae latae, hip flexors, and piriformis to restore ranges of motion in hip adduction, extension, and internal rotation. Attention should be paid to lumbosacroiliac mechanics to ensure resolution of any dysfunction there. Anterior or posterior rotational innominate (iliac) dysfunctions affect the origin of the tensor fasciae latae and can delay recovery if left untreated.

Other specific areas to address with manipulation include the T12-L1 vertebral segments (origin of the iliopsoas) and the fibular head (partial insertion point of the ITB). In fact, fibular head dysfunction (either anterior or posterior rotation) not only can contribute to ITBFS but can mimic it as well.

Recovery phase

Progressive strengthening exercises are started to restore muscle strength lost from inhibition and disuse. Exercises include side-lying leg lifts, pelvic drops, and step-down exercises.

Return to running

The angle of the knee during faster-paced running is beyond the friction point of ITBFS. The patient should start with easy sprints on even surfaces, no more than every other day at first, and then may gradually increase distance and frequency according to tolerance. Time to return to sports depends on the initial severity. Patients who return must first perform all strength exercises and stretches without pain. Most people return to their sport or running within 4-6 weeks.

Previous
Next

Surgical Therapy

The typical surgical treatment is an open procedure used to resect a small triangular portion of the posterior ITB over the lateral femoral epicondyle. Studies demonstrated positive results with the knee flexed at 30° during the procedure.[23, 24, 25]

A resection of the underlying synovial tissue can also be performed, but some question exists as to whether it should be resected. Resection can cause chronic synovial fluid effusion in the recess and hematoma formation.

However, arthroscopic procedures are becoming more commonly used in ITBFS specifically to resect tissue in the lateral synovial recess and separate the band from the lateral condyle.[26, 27] Arthroscopy limits the amount of bleeding, and the incidence of hematoma formation can be reduced.

The procedure requires no special equipment other than what is common and appropriate for knee arthroscopy. The patient can be positioned with the operative leg in a leg holder hanging off the end of the bed, or using a lateral post while supported by the bed. Resection of the synovial tissue in the lateral recess and gutter is typically accomplished with a shaver blade. (See the image below.)

Resection of lateral synovial fold through arthros Resection of lateral synovial fold through arthroscopic knee procedure. Courtesy of Elsevier, Inc (Cowden CH 3rd, Barber FA. Arthroscopic treatment of iliotibial band syndrome. Arthrosc Tech. Feb 2014;3(1):e57-60).

Surgical correction of anatomic variants leading to iliotibial band syndrome, such as severe genu valgum, must be considered carefully and with the entire well-being of the patient in mind.[28]

Procedural details

The patient is restricted to taking nothing by mouth at least 8 hours before the procedure. If an ITB resection is being performed through an arthroscopic procedure, the patient is prepared for surgery similar to that for any such procedure. Otherwise, a tourniquet is applied to provide adequate hemostasis. Anesthesia can be achieved by general or epidural administration. The affected leg is positioned so that the lateral femoral condylar region is exposed.

With the knee in 30° of flexion, a longitudinal incision is made centered over the lateral epicondyle. The posterior portion of the ITB is then exposed. The knee is flexed and extended to identify the portion of the ITB that is impinging on the lateral epicondyle. A triangular piece of the ITB is then resected. The base of the triangle is approximately 2 cm and centered over the posterior fibers of the ITB. The height of the triangle is roughly 1.5 cm. The knee is then moved through the full range of motion to confirm adequate release of the ITB. The wound is then irrigated and closed. Excision of an elliptical section of the ITB also has been described.

Previous
Next

Postoperative Care

Some controversy exists regarding postoperative immobilization. Martens et al[29] advocated splinting the knee in extension for 1 week postoperatively, followed by a gradual return to activity. In a study by Holmes et al,[30] a soft dressing was applied and bicycling was allowed on postoperative day 3. In this study, nine of 21 patients developed a small seroma near the lateral incision, which subsequently resolved with rest and icing.

Previous
Next

Complications

Potential complications include the following:

  • Recurrent swelling in the lateral synovial recess
  • Persistent bleeding
  • Bisection of the ITB
  • Infection
  • Seroma
  • Recurrent pain
  • Impingement
Previous
 
Contributor Information and Disclosures
Author

Steven J Karageanes, DO, FAOASM Director of Sports Medicine, St Mary Mercy Hospital Livonia; Regional Assistant Dean, Kansas City University of Medicine and Biosciences; Clinical Assistant Professor, Michigan State University College of Osteopathic Medicine

Steven J Karageanes, DO, FAOASM is a member of the following medical societies: American Medical Association, American Osteopathic Academy of Sports Medicine, American Osteopathic Association, Michigan State Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

Terrence Lock, MD Senior Consulting Surgeon, Department of Orthopedic Surgery, Henry Ford Hospital

Terrence Lock, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, American Medical Association, Michigan State Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Thomas M DeBerardino, MD Associate Professor, Department of Orthopedic Surgery, Consulting Surgeon, Sports Medicine, Arthroscopy and Reconstruction of the Knee, Hip and Shoulder, Team Physician, Orthopedic Consultant to UConn Department of Athletics, University of Connecticut Health Center

Thomas M DeBerardino, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Orthopaedic Society for Sports Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Arthrex, Inc.; Ivy Sports Medicine; MTF; Aesculap; The Foundry, Cotera; ABMT<br/>Received research grant from: Histogenics; Cotera; Arthrex.

Additional Contributors

Dennis P Grogan, MD Clinical Professor (Retired), Department of Orthopedic Surgery, University of South Florida College of Medicine; Orthopedic Surgeon, Department of Orthopedic Surgery, Shriners Hospital for Children of Tampa

Dennis P Grogan, MD is a member of the following medical societies: American Medical Association, American Orthopaedic Association, Scoliosis Research Society, Irish American Orthopaedic Society, Pediatric Orthopaedic Society of North America, American Academy of Orthopaedic Surgeons, American Orthopaedic Foot and Ankle Society, Eastern Orthopaedic Association

Disclosure: Nothing to disclose.

Acknowledgements

Cynthia Kooima, MD Resident Physician, Department of Orthopedic Surgery, Henry Ford Hospital

Cynthia Kooima, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

References
  1. Ellis R, Hing W, Reid D. Iliotibial band friction syndrome--a systematic review. Man Ther. 2007 Aug. 12(3):200-8. [Medline].

  2. Hamill J, Miller R, Noehren B, Davis I. A prospective study of iliotibial band strain in runners. Clin Biomech (Bristol, Avon). 2008 Jun 24. [Medline].

  3. Kirk KL, Kuklo T, Klemme W. Iliotibial band friction syndrome. Orthopedics. 2000 Nov. 23(11):1209-14; discussion 1214-5; quiz 1216-7. [Medline].

  4. Lebsack D, Gieck J, Saliba E. Iliotibial band friction syndrome. JNATA. 1990:356-61.

  5. Fairclough J, Hayashi K, Toumi H, Lyons K, Bydder G, Phillips N, et al. The functional anatomy of the iliotibial band during flexion and extension of the knee: implications for understanding iliotibial band syndrome. J Anat. 2006 Mar. 208(3):309-16. [Medline].

  6. Krivickas LS. Anatomical factors associated with overuse sports injuries. Sports Med. 1997 Aug. 24(2):132-46. [Medline].

  7. Biundo JJ Jr, Irwin RW, Umpierre E. Sports and other soft tissue injuries, tendinitis, bursitis, and occupation-related syndromes. Curr Opin Rheumatol. 2001 Mar. 13(2):146-9. [Medline].

  8. DeLee JC, Drez D. Orthopaedic Sports Medicine: Principles and Practice. Vol 2. WB Saunders Co. 1994:1251-1252.

  9. Noble CA. Iliotibial band friction syndrome in runners. Am J Sports Med. 1980 Jul-Aug. 8(4):232-4. [Medline].

  10. Orchard JW, Fricker PA, Abud AT, Mason BR. Biomechanics of iliotibial band friction syndrome in runners. Am J Sports Med. 1996 May-Jun. 24(3):375-9. [Medline].

  11. Strauss EJ, Kim S, Calcei JG, Park D. Iliotibial band syndrome: evaluation and management. J Am Acad Orthop Surg. 2011 Dec. 19(12):728-36. [Medline].

  12. Baker RL, Souza RB, Fredericson M. Iliotibial band syndrome: soft tissue and biomechanical factors in evaluation and treatment. PM R. 2011 Jun. 3(6):550-61. [Medline].

  13. Fredericson M, Cookingham CL, Chaudhari AM, et al. Hip abductor weakness in distance runners with iliotibial band syndrome. Clin J Sport Med. 2000 Jul. 10(3):169-75. [Medline].

  14. Fredericson MF, Guillet M, DeBenedictis L. Quick solutions for iliotibial band syndrome. Phys Sports Med. 2000. 28(2):53-68.

  15. Ho GW1, Howard TM. Greater trochanteric pain syndrome: more than bursitis and iliotibial tract friction. Curr Sports Med Rep. Sept-Oct 2012. 11(5):232-8. [Medline].

  16. Taketomi S1, Inui H, Hirota J, Nakamura K, Sanada T, Masuda H, et al. Iliotibial band irritation caused by the EndoButton after anatomic double-bundle anterior cruciate ligament reconstruction: report of two cases. Knee. August 2013. 20:291-4. [Medline].

  17. Linenger JM, Christensen CP. Is iliotibial band syndrome overlooked?. Phys Sports Med. 1992. 20:98-108.

  18. Nemeth WC, Sanders BL. The lateral synovial recess of the knee: anatomy and role in chronic Iliotibial band friction syndrome. Arthroscopy. 1996 Oct. 12(5):574-80. [Medline].

  19. Firer P. Results of surgical management for iliotibial band friction syndrome. Clin J Sport Med. 1992. 2:247-50.

  20. Ekman EF, Pope T, Martin DF, Curl WW. Magnetic resonance imaging of iliotibial band syndrome. Am J Sports Med. 1994 Nov-Dec. 22(6):851-4. [Medline].

  21. Muhle C, Ahn JM, Yeh L, et al. Iliotibial band friction syndrome: MR imaging findings in 16 patients and MR arthrographic study of six cadaveric knees. Radiology. 1999 Jul. 212(1):103-10. [Medline].

  22. Murphy BJ, Hechtman KS, Uribe JW, et al. Iliotibial band friction syndrome: MR imaging findings. Radiology. 1992 Nov. 185(2):569-71. [Medline].

  23. Drogset JO, Rossvoll I, Grontvedt T. Surgical treatment of iliotibial band friction syndrome. A retrospective study of 45 patients. Scand J Med Sci Sports. 1999 Oct. 9(5):296-8. [Medline].

  24. Sangkaew C. Surgical treatment of iliotibial band friction syndrome with the mesh technique. Arch Orthop Trauma Surg. 2007 May. 127(4):303-6. [Medline].

  25. Barber FA, Boothby MH, Troop RL. Z-plasty lengthening for iliotibial band friction syndrome. J Knee Surg. 2007 Oct. 20(4):281-4. [Medline].

  26. Cowden CH 3rd, Barber FA. Arthroscopic treatment of iliotibial band syndrome. Arthrosc Tech. 2013 Dec. 19;3(1):57-60. [Medline]. [Full Text].

  27. Michels F1, Jambou S, Allard M, Bousquet V, Colombet P, de Lavigne C. An arthroscopic technique to treat the iliotibial band syndrome. Knee Surg Sports Traumatol Arthrosc. 2009 March. 17(3):233-6. [Medline].

  28. Weiner DS1, Tank JC, Jonah D, Morscher MA, Krahe A, Kopits S, et al. An operative approach to address severe genu valgum deformity in the Ellis-van Creveld syndrome. J Child Orthop. 2014 Feb. 8(1):61-9. [Medline].

  29. Martens M, Libbrecht P, Burssens A. Surgical treatment of the iliotibial band friction syndrome. Am J Sports Med. 1989 Sep-Oct. 17(5):651-4. [Medline].

  30. Holmes JC, Pruitt AL, Whalen NJ. Iliotibial band syndrome in cyclists. Am J Sports Med. 1993 May-Jun. 21(3):419-24. [Medline].

 
Previous
Next
 
Illustration of the friction point at the lateral epicondyle prominence. Note the shift in position of the iliotibial band from anterior to posterior as the knee moves into flexion, drawing the iliotibial band across the prominence.
Lateral hip stabilizers.
Iliotibial band noted prominently along the lateral thigh.
Iliotibial band at the lateral femoral epicondyle, with the posterior fibers denoted.
The Thomas test can be used to evaluate restriction in the iliotibial band, hip flexors, and rectus femoris.
Resection of lateral synovial fold through arthroscopic knee procedure. Courtesy of Elsevier, Inc (Cowden CH 3rd, Barber FA. Arthroscopic treatment of iliotibial band syndrome. Arthrosc Tech. Feb 2014;3(1):e57-60).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.